Ajovy is first anti-CGRP treatment available at monthly and quarterly doses
| The third new generation of CGRP antibody has been approved. It’s called Emgality (galcanezumab) which was just approved by the FDA on September 27th. |
| · Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies. |
| · Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies. |
(2018-09-14)
Read the article in MigraineAgain.com >>>
